2022 annual financial data
Barinthus Biotherapeutics 2022 Operating margin
Barinthus Biotherapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -9.04%.
Operating income was -4,041,000 USD and net income was 5,342,000 USD.
Operating cash flow was -14,431,000 USD.
Get free Barinthus Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 44,703,000 USD
- Operating income
- -4,041,000 USD
- Net income
- 5,342,000 USD
- Operating cash flow
- -14,431,000 USD